SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-18-000015
Filing Date
2018-07-27
Accepted
2018-07-26 18:58:06
Documents
85
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2018630x10q.htm 10-Q 2035036
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2018630xq2.htm EX-31 23706
3 SECTION 1350 CERTIFICATIONS amgn-ex32_2018630xq2.htm EX-32 10895
  Complete submission text file 0000318154-18-000015.txt   11816091

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT amgn-20180630.xml EX-101.INS 3475597
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20180630.xsd EX-101.SCH 63584
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20180630_cal.xml EX-101.CAL 94245
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20180630_def.xml EX-101.DEF 358823
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20180630_lab.xml EX-101.LAB 783162
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20180630_pre.xml EX-101.PRE 497061
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 18972830
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1